Bausch Health Companies (TSE:BHC) Shares Down 1.9% – Should You Sell?

Bausch Health Companies Inc. (TSE:BHC) fell 1.9% during mid-day trading on Tuesday . The stock traded as low as C$7.30 and last traded at C$7.33. 346,542 shares traded hands during mid-day trading, a decline of 25% from the average session volume of 462,667 shares. The stock had previously closed at C$7.47.

Bausch Health Companies Price Performance

The company has a debt-to-equity ratio of -1,009.96, a current ratio of 1.32 and a quick ratio of 0.58. The company’s 50-day simple moving average is C$7.45 and its 200-day simple moving average is C$8.47. The company has a market cap of C$2.74 billion, a price-to-earnings ratio of -2.26, a P/E/G ratio of 0.21 and a beta of 0.63.

Bausch Health Companies (TSE:BHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported C$1.08 EPS for the quarter. Bausch Health Companies had a positive return on equity of 120.43% and a negative net margin of 13.54%.The business had revenue of C$3.51 billion during the quarter. On average, equities research analysts anticipate that Bausch Health Companies Inc. will post 5.5472637 EPS for the current year.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.